SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

CK-MB Rapid Quantitative Test

CK-MB is very valuable for the early diagnosis of AMI. The Biotime CK-MB test kit can perform the test accurately and rapidly within 15 minutes with Biotime Analyzers.

cTnI Rapid Quantitative Test

cTnI is a myocardial marker with high specificity and good sensitivity. The Biotime cTnI test kit has a wide detection range and high accuracy.

hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)

hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the high sensitivity cardiac troponin I (hs-cTnI) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay)

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the D-Dimer concentration in human sodium citrate anticoagulant-contained plasma (1:9) and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay)

h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the heart-type fatty acid binding protein (h-FABP) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

ST2 Rapid Quantitative Test

ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A